USPTO serial 79422140
REVOLAX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 10, 2026
- Examiner
- STRUCK, ROBERT J
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with REVOLAX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
David Youngjoon Jung
David Youngjoon Jung KAIROS Law Firm, PLLC2001 L Street N.W. Suite 500Washington, DC 20036United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medicated preparations for skin treatment; injectable dermal fillers; vitamin drops; pharmaceutical preparations for skin care; skin lotions for pharmaceutical purposes; medicated ointments for pharmaceutical purposes for treating dermatological conditions; pharmaceutical agents for epidermis; medicated skin care preparations; pharmaceutical preparation in the form of gel for treating dermatological conditions; pharmaceutical preparation in the form of gel for skin care; pharmaceutical preparation in the form of gel for treating skin disorders; pharmaceutical preparation in the form of gel for treating sunburn; pharmaceutical preparation in the form of gel for treating wounds; preparations of microorganisms for medical use; medicated plasters; pharmaceutical preparations for injection for skin moisturizing and wrinkle reduction; preparations for callouses, namely, callus creams; pharmaceutical preparations for use in dermatology; antimicrobials for dermatologic use; pharmaceutical preparations for treating skin disorders; medicated skin care preparations mainly based on hyaluronic acid; medicated skin care preparations for medical purposes; amino acid preparations for medical purposes. | ACTIVE | — |
| 010 | Medical instruments incorporating lasers for treating dermatological preparations; medical instruments incorporating lasers for surgical use; medical instruments incorporating lasers for skin treatment; medical instruments incorporating lasers for the cosmetic treatment of the face and skin; medical skin enhancement apparatus using lasers; medical apparatus for treating urological conditions; medical apparatus and instruments for plastic surgery; medical instruments for treating dermatological preparations; medical instruments, namely, orthopedic apparatus and instruments; medical instruments, namely, biosensors for detecting infectious diseases; medical instruments, namely, surgical thread; medical instruments for surgical purposes; medical apparatus and instruments for treating dermatological preparations; medical apparatus and instruments, namely, surgical apparatus and instruments; medical apparatus and instruments for skin improvement with LED light; medical apparatus and instruments for surgical purposes; medical apparatus for treating dermatological preparations; medical apparatus, namely, lasers for the cosmetic treatment of the face and skin; medical apparatus, namely, infusion and injection devices for administering drugs; medical apparatus, namely, electronic light therapy apparatus for the skin; skin wrinkle removal apparatus for medical purposes; syringes for medical purposes; medical injection syringe; medical surgical instruments for use in dermatoplasty; medical apparatus for injecting dermal fillers; medical apparatus for injecting dermal fillers of hyaluronic acid; medical, surgical and orthopaedic implants made of artificial materials; hypodermic syringes for injections for medical purposes; syringes for injections; medical laser for skin treatment; artificial biomaterials for dermatology, namely, artificial skin for surgical purposes; skin regeneration therapy apparatus, namely, electronic light therapy apparatus for the skin; skin regeneration therapy apparatus being a high frequency electromagnetic therapy apparatus; medical apparatus and instruments for the treatment of skin. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 8, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Sep 23, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 23, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Sep 10, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 26, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 26, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 10, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 26, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 26, 2026 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Mar 26, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 26, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 10, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Mar 10, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 20, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 20, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 14, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 19, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 9, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 9, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 9, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 30, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 9, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 9, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 24, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 23, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 23, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 25, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 25, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 24, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |